title: The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study.
abstract: Population pharmacokinetics and simulation techniques currently play an important role in new drug development. This paper illustrates the potential value of those methods in postmarketing safety assessment, using buflomedil in elderly patients as an example. We retrospectively assessed the risk of buflomedil overdosing associated with the latest dosing recommendations of the French Drug Agency (AFSSAPS). First, buflomedil concentrations measured in 24 elderly patients were analysed with a nonparametric population approach. Then, the pharmacokinetic model was used to perform a 1000-patient Monte Carlo simulation for the two recommended buflomedil dosage regimens. The maximum concentrations calculated after 10 days of therapy were compared with levels observed in reported cases of toxicity to assess the probability of overdosing. A three-compartment model best fit concentration data. Population predictions showed little bias (-0.14 mg/L) and good precision (8.73 mg(2) /L(2)). Overall results of the simulation study showed that the application of the two recommended dosage regimens of buflomedil was associated with overdosing (C(max) > 10 mg/L) and potential toxicity in 2.9% of geriatric patients. In patients with mild renal impairment, who may receive the higher-dosage regimen by therapeutic error, the probability of overdosing was 6.2%. Despite specific dosing recommendations in case of renal impairment, this study shows that the use of buflomedil could be associated with significant risk of overdosing in geriatric patients. Such results might have enhanced decision-making when buflomedil safety was reassessed by AFSSAPS in 2006. The retrospective case of buflomedil illustrates how these methods may be valuable in postmarketing safety evaluation of potentially toxic drugs.
authors: Université de Lyon, Université Lyon 1, Lyon F-69003, France. laurent.bourguignon@chu-lyon.fr
authors: Laurent
authors: L
authors: Bourguignon
authors: Michel
authors: M
authors: Ducher
authors: David
authors: D
authors: Matanza
authors: Nathalie
authors: N
authors: Bleyzac
authors: Mathieu
authors: M
authors: Uhart
authors: Emmanuel
authors: E
authors: Odouard
authors: Pascal
authors: P
authors: Maire
authors: Sylvain
authors: S
authors: Goutelle
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003198:Computer Simulation; D004305:Dose-Response Relationship, Drug; D062787:Drug Overdose; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008954:Models, Biological; D009010:Monte Carlo Method; D017410:Practice Guidelines as Topic; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D011759:Pyrrolidines / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D012189:Retrospective Studies; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics
chemical_list: D011759:Pyrrolidines; D014665:Vasodilator Agents; C010651:buflomedil